Veru (VERU) Goodwill & Intangibles (2016 - 2026)

Veru (VERU) posted quarterly Goodwill & Intangibles of $6.9 million for Q3 2025, little changed quarter-over-quarter from $6.9 million in Q2 2025.

Veru (VERU) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

Veru (VERU) has reported Goodwill & Intangibles for 9 consecutive years, with $6.9 million the latest figure, recorded in Q3 2025.

In Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $6.9 million; the TTM figure through Sep 2025 stood at $6.9 million (changed N/A YoY), while the FY2025 annual figure was $6.9 million, changed N/A from the prior year.
Goodwill & Intangibles held at $6.9 million in Q3 2025 per VERU's latest filing, from $6.9 million in the prior quarter.
Across five years, Goodwill & Intangibles topped out at $10.9 million in Q3 2022 and bottomed at $5952.0 in Q3 2023.
Historically, Goodwill & Intangibles has averaged $4.2 million across 4 years, with a median of $4.1 million in 2021.
Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 168.14% — and 2023, when it slumped 99.95%.
Veru's Goodwill & Intangibles stood at $4.4 million in 2021, then retreated by 10.01% to $4.0 million in 2022, then plunged by 99.85% to $5952.0 in 2023, then soared by 115827.42% to $6.9 million in 2025.
Business Quant data shows VERU's Goodwill & Intangibles at $6.9 million in Q3 2025, $6.9 million in Q2 2025, and $5952.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Veru	60.85 Mn	35.06 Mn	-

Download Data